Cape Ann Savings Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-9,496
Closed -$255K 66
2016
Q2
$255K Buy
9,496
+100
+1% +$2.74K 0.35% 60
2016
Q1
$254K Buy
9,396
+168
+2% +$4.5K 0.35% 60
2015
Q4
$268K Buy
9,228
+724
+9% +$20K 0.37% 60
2015
Q3
$231K Hold
8,504
0.34% 62
2015
Q2
$233K Buy
8,504
+132
+2% +$3.71K 0.33% 64
2015
Q1
$224K Buy
+8,372
New +$193K 0.31% 65

Other funds holding NVO

Cape Ann Savings Bank's NVO Position: Q3 2016 in Review

Cape Ann Savings Bank sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 9,496 shares — an estimated $255K sold.

Cape Ann Savings Bank first reported a position in NVO in Q1 2015 and held it in 6 quarters. The position peaked at $268K in Q4 2015. 512 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Cape Ann Savings Bank reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
  • Cape Ann Savings Bank sold 9,496 Novo Nordisk shares in Q3 2016, an estimated $255K.
  • Cape Ann Savings Bank first reported a position in Novo Nordisk in Q1 2015 and held it in 6 quarters.
  • Cape Ann Savings Bank's Novo Nordisk position peaked at $268K in Q4 2015.
  • 512 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Cape Ann Savings Bank's 13F filing for Q3 2016, filed 20 Oct 2016.